AUTOMATED GMP-COMPATIBLE CRISPR-CAS9 EDITING OF HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) FOR THE TREATMENT OF β-HEMOGLOBINOPATHIES

被引：0
|
作者：
Urena-Bailen, G. [1 ,2 ]
Block, M.
机构：
[1] Miltenyi Biotec BV & Co KG, Bergisch Gladbach, Nordrhein Westf, Germany
[2] Univ Klinikum Tubingen, Oncol & Hematol, Tubingen, Baden Wurttembe, Germany
来源：
CYTOTHERAPY | 2023年 / 25卷 / 06期
关键词：
beta-hemoglobnopathies; GMP-compatible; CRISPR-Cas9;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
402
引用
收藏
页码：S124 / S124
页数：1
相关论文
共 50 条
  • [1] Automated GMP-compatible CRISPR-Cas9 editing of hematopoietic stem and progenitor cells (HSPCs) for the treatment of β-hemoglobinopathies
    Block, M.
    Urena-Bailen, G.
    Grandi, T.
    Aivazidou, F.
    Quednau, J.
    Krenz, D.
    Daniel-Moreno, A.
    Lamsfus-Calle, A.
    Epting, T.
    Handgretinger, R.
    Wild, S.
    Mezger, M.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A179 - A180
  • [2] Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies
    Urena-Bailen, Guillermo
    Block, Milena
    Grandi, Tommaso
    Aivazidou, Faidra
    Quednau, Jona
    Krenz, Dariusz
    Daniel-Moreno, Alberto
    Lamsfus-Calle, Andres
    Epting, Thomas
    Handgretinger, Rupert
    Wild, Stefan
    Mezger, Markus
    CRISPR JOURNAL, 2023, 6 (01): : 5 - 16
  • [3] Efficient GMP-compatible CRISPR-Cas mediated genome editing in hematopoietic stem and progenitor cells
    Turchiano, G.
    Haas, S.
    Hildenbeutel, M.
    Pennucci, V.
    Cornu, T. I.
    Cathomen, T.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 : 81 - 81
  • [4] Efficient GMP-compatible CRISPR/Cas mediated genome editing in haematopoietic stem and progenitor cells
    Turchiano, G.
    Haas, S. A.
    Hildenbeutel, M.
    Pennucci, V.
    Cornu, T. I.
    Cathomen, T.
    HUMAN GENE THERAPY, 2017, 28 (12) : A55 - A55
  • [5] Efficient gene editing in hematopoietic stem/progenitor cells with the CRISPR-Cas9 system
    Gori, J. L.
    Heath, J. M.
    Collins, M. A.
    Fang, J. W.
    Friedland, A. E.
    Welstead, G. G.
    Bumcrot, D.
    HUMAN GENE THERAPY, 2015, 26 (10) : A49 - A49
  • [6] CRISPR-Cas9 Genome Editing of γ-Globin Promoters in Human Hematopoietic Stem Cells to Induce Erythrocyte Fetal Hemoglobin for Treatment of β-Hemoglobinopathies
    Metais, Jean-Yves
    Doerfler, Phillip A.
    Mayuranathan, Thiyagaraj
    Bauer, Daniel E.
    Fowler, Stephanie
    Hsieh, Matthew
    Katta, Varun
    Keriwala, Sagar
    Lazzarotto, Cicera
    Luk, Kevin
    Neel, Michael
    Perry, Scott
    Porter, Shaina
    Ryu, Byoung Y.
    Sharma, Akshay
    Shea, Devlin
    Peters, Samuel
    Tisdale, John F.
    Wolfe, Scot A.
    Woodard, Kaitly Jensen
    Uchida, Naoya
    Wu, Yuxuan
    Yao, Yu
    Zeng, Jing
    Pruett-Miller, Shondra M.
    Tsai, Shengdar Q.
    Weiss, Mitchell J.
    BLOOD, 2019, 134
  • [7] Multiplexing CRISPR-Cas9 Genome Editing in Human Hematopoietic Stem and Effector Cells
    Dever, Daniel P.
    Bak, Rasmus O.
    Reinisch, Andreas
    Cruz, David
    Majeti, Ravindra
    Porteus, Matthew
    MOLECULAR THERAPY, 2017, 25 (05) : 343 - 343
  • [8] CRISPR-Cas9 Edited Hematopoietic Stem and Progenitor Cells for Friedreich's Ataxia
    Sivakumar, Anusha
    Rainaldi, Joseph N.
    Wan, Rita
    Rocca, Celine J.
    Cherqui, Stephanie
    MOLECULAR THERAPY, 2022, 30 (04) : 135 - 135
  • [9] Gene Editing with Crispr-Cas9 for Treating Beta-Hemoglobinopathies
    Lee, Ciaran
    Bao, Gang
    Porteus, Matthew H.
    Cornu, Tatjana
    Miccio, Annarita
    Cradick, Thomas
    Cathomen, Toni
    Lundberg, Ante
    Mavilio, Fulvio
    BLOOD, 2015, 126 (23)
  • [10] Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    Papizan, James B.
    Porter, Shaina N.
    Sharma, Akshay
    Pruett-Miller, Shondra M.
    JOURNAL OF BIOMEDICAL RESEARCH, 2021, 35 (02): : 115 - 134
12345